Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Omar M. Rashid
Jose M. Pimiento
Andrew W. Gamenthaler
Phuong Nguyen
Tin T. Ha
Tai Hutchinson
Gregory Springett
Sarah Hoffe
Ravi Shridhar
Pamela J. Hodul
Brad L. Johnson
Karl Illig
Paul A. Armstrong
Barbara A. Centeno
William J. Fulp
Dung-Tsa Chen
Mokenge P. Malafa
机构：
[1] H. Lee Moffitt Cancer Center and Research Institute,Department of Gastrointestinal Oncology
[2] University of South Florida,Department of Biostatistics
[3] H. Lee Moffitt Cancer Center and Research Institute,undefined
来源：
Annals of Surgical Oncology | 2016年 / 23卷
关键词：
Overall Survival; Pancreatic Cancer; National Comprehensive Cancer Network; National Comprehensive Cancer Network; Clinical Pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1371 / 1379
页数：8
相关论文
共 50 条
  • [21] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [22] Management of borderline resectable pancreatic cancer
    Amit Mahipal
    Jessica Frakes
    Sarah Hoffe
    Richard Kim
    World Journal of Gastrointestinal Oncology, 2015, (10) : 241 - 249
  • [23] Management of borderline resectable pancreatic cancer
    Mahipal, Amit
    Frakes, Jessica
    Hoffe, Sarah
    Kim, Richard
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (10) : 241 - 249
  • [24] Management of Borderline Resectable Pancreatic Cancer
    Katz, Matthew H. G.
    Crane, Christopher H.
    Varadhachary, Gauri
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (02) : 105 - 112
  • [25] Management of Borderline Resectable Pancreatic Cancer
    Toesca, Diego A. S.
    Koong, Amanda J.
    Poultsides, George A.
    Visser, Brendan C.
    Haraldsdottir, Sigurdis
    Koong, Albert C.
    Chang, Daniel T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1155 - 1174
  • [26] Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy
    Shaina Templeton
    Michael Moser
    Chris Wall
    John Shaw
    Haji Chalchal
    Yigan Luo
    Adnan Zaidi
    Shahid Ahmed
    Journal of Gastrointestinal Cancer, 2021, 52 : 529 - 535
  • [27] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [28] Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy
    Templeton, Shaina
    Moser, Michael
    Wall, Chris
    Shaw, John
    Chalchal, Haji
    Luo, Yigan
    Zaidi, Adnan
    Ahmed, Shahid
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (02) : 529 - 535
  • [29] Early outcomes following neoadjuvant therapy for borderline resectable pancreatic cancer
    Goody, R.
    Arunsingh, M.
    Murray, L.
    Adair, R.
    Albazaz, R.
    Anthoney, A.
    Beckett, C.
    Cairns, A.
    Collinson, F.
    Guthrie, A.
    Kenyon, A.
    Macutkiewicz, C.
    Sanni, L.
    Sheridan, M.
    Smith, A.
    Trainor, P.
    Radhakrishna, G.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S776 - S777
  • [30] Pancreatic Cancer Deinition and Treatment of the "borderline"-resectable Pancreatic Cancer
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2015, 140 (01): : 6 - 6
12345